Sam68 expression and cytoplasmic localization is correlated with lymph node metastasis as well as prognosis in patients with early-stage cervical cancer
- PMID: 21700735
- DOI: 10.1093/annonc/mdr290
Sam68 expression and cytoplasmic localization is correlated with lymph node metastasis as well as prognosis in patients with early-stage cervical cancer
Abstract
Background: This study was aimed at investigating the role and molecular mechanism of Sam68 in cervical cancer lymph node metastasis.
Materials and methods: Sam68 expression profile was detected by quantitative polymerase chain reaction, western blotting and immunohistochemical staining. Short hairpin RNA interfering approach was employed to suppress endogenous Sam68 expression in cervical cancer cells to determine its role in metastasis and the possible mechanism.
Results: Sam68 expression in cervical cancer was significantly up-regulated at both messenger RNA and protein levels compared with that in normal cervical tissues. The high expression level of Sam68 and its cytoplasmic localization were significantly associated with risk factors including pelvic lymph node metastasis (P < 0.001), and served as independent prognostic factors for predicting shortening of the overall survival time and disease-free survival time in patients with early-stage cervical cancer. Moreover, down-regulation of Sam68 in cervical cancer cells remarkably inhibited cellular motility and invasion. In addition, down-regulation of Sam68 reversed epithelial-mesenchymal transition through inhibiting the Akt/ GSK-3β/Snail pathway.
Conclusion: This study demonstrated that Sam68 could induce cervical cancer lymph node metastasis through regulating epithelial-mesenchymal transition, and Sam68 expression profile possessed the potential to serve as predictors of pelvic lymph node metastasis in cervical cancer patients.
Similar articles
-
Clinical significance of Sam68 expression in endometrial carcinoma.Tumour Biol. 2015 Jun;36(6):4509-18. doi: 10.1007/s13277-015-3095-x. Epub 2015 Jan 21. Tumour Biol. 2015. PMID: 25874492
-
Sam68 promotes cellular proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.Tumour Biol. 2015 Nov;36(11):8735-45. doi: 10.1007/s13277-015-3631-8. Epub 2015 Jun 7. Tumour Biol. 2015. PMID: 26050229
-
Expression and cytoplasmic localization of SAM68 is a significant and independent prognostic marker for renal cell carcinoma.Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2685-93. doi: 10.1158/1055-9965.EPI-09-0097. Epub 2009 Sep 15. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19755649
-
Sam68 is Overexpressed in Epithelial Ovarian Cancer and Promotes Tumor Cell Proliferation.Med Sci Monit. 2016 Sep 13;22:3248-56. doi: 10.12659/msm.899980. Med Sci Monit. 2016. PMID: 27623016 Free PMC article.
-
Role of Sam68 in different types of cancer (Review).Int J Mol Med. 2025 Jan;55(1):3. doi: 10.3892/ijmm.2024.5444. Epub 2024 Oct 25. Int J Mol Med. 2025. PMID: 39450529 Free PMC article. Review.
Cited by
-
Sam68 functions as a transcriptional coactivator of the p53 tumor suppressor.Nucleic Acids Res. 2016 Oct 14;44(18):8726-8741. doi: 10.1093/nar/gkw582. Epub 2016 Jun 30. Nucleic Acids Res. 2016. PMID: 27365047 Free PMC article.
-
High expression of Sam68 contributes to metastasis by regulating vimentin expression and a motile phenotype in oral squamous cell carcinoma.Oncol Rep. 2022 Oct;48(4):183. doi: 10.3892/or.2022.8398. Epub 2022 Sep 9. Oncol Rep. 2022. PMID: 36082807 Free PMC article.
-
A comprehensive study on genome-wide coexpression network of KHDRBS1/Sam68 reveals its cancer and patient-specific association.Sci Rep. 2019 Jul 31;9(1):11083. doi: 10.1038/s41598-019-47558-x. Sci Rep. 2019. PMID: 31366900 Free PMC article.
-
Role of Sam68 in Sunitinib induced renal cell carcinoma apoptosis.Cancer Med. 2022 Oct;11(19):3674-3686. doi: 10.1002/cam4.4743. Epub 2022 Apr 10. Cancer Med. 2022. PMID: 35476809 Free PMC article.
-
Clinical significance of Sam68 expression in endometrial carcinoma.Tumour Biol. 2015 Jun;36(6):4509-18. doi: 10.1007/s13277-015-3095-x. Epub 2015 Jan 21. Tumour Biol. 2015. PMID: 25874492